Stay updated on Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.

Latest updates to the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page
- Check6 days agoChange DetectedAdded a new Revision: v3.5.4 entry to the Study Record History, replacing the previous Revision: v3.5.3 entry and indicating an update to the page's version history.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThis update reflects a revision/version bump on the ClinicalTrials.gov page (v3.5.0 → v3.5.3), with no accompanying changes to the displayed study record history content.SummaryDifference0.1%

- Check64 days agoChange DetectedAddition of Revision v3.5.0 and deletion of Revision v3.4.3 in the record history.SummaryDifference0.1%

- Check78 days agoChange DetectedRevision: v3.4.3 was added to the record history and Revision: v3.4.2 was removed.SummaryDifference0.1%

- Check99 days agoChange DetectedA new revision entry (v3.4.2) was added and the previous revision (v3.4.1) was deleted in the record history, indicating a minor metadata update to the study record history. No substantive changes to core study data or page content were observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check107 days agoChange DetectedThe record history shows a new revision entry (v3.4.1) added and a previous one (v3.4.0) removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pyrotinib Maleate in HER2-Positive Solid Tumors Clinical Trial page.